Hologic Net Long-Term Debt 2010-2025 | HOLX
Hologic annual/quarterly net long-term debt history and growth rate from 2010 to 2025. Net long-term debt can be defined as the net amount of long term debt issued and repaid. This field is either calculated as the sum of the long term debt fields or used if a company does not report debt issued and repaid separately
- Hologic net long-term debt for the quarter ending March 31, 2025 was $-0.020B, a 92.46% decline year-over-year.
- Hologic net long-term debt for the twelve months ending March 31, 2025 was $-0.603B, a 6.78% increase year-over-year.
- Hologic annual net long-term debt for 2024 was $-0.291B, a 1433.16% increase from 2023.
- Hologic annual net long-term debt for 2023 was $-0.019B, a 152.49% decline from 2022.
- Hologic annual net long-term debt for 2022 was $0.036B, a 110% decline from 2021.
| Hologic Annual Net Long-Term Debt (Millions of US $) |
|
|---|---|
| 2024 | $-291 |
| 2023 | $-19 |
| 2022 | $36 |
| 2021 | $-362 |
| 2020 | $203 |
| 2019 | $-269 |
| 2018 | $-143 |
| 2017 | $-137 |
| 2016 | $-693 |
| 2015 | $-1,144 |
| 2014 | $-595 |
| 2013 | $-265 |
| 2012 | $3,476 |
| 2011 | $-1 |
| 2010 | $N/A |
| 2009 | $N/A |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $14.697B | $4.030B |
| Hologic Inc. develops, manufactures, and supplies diagnostics, medical imaging systems and surgical products which cater to the healthcare needs of women. Hologic operates through the following four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. | |||